Effects of the egg protein hydrolysate NWT-03 on cognitive function in men and women with the metabolic syndrome: a randomized, double-blind, placebo-controlled study

References

• Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–7.
   PubMed Web of Science ®Google Scholar
• Assuncao N, Sudo FK, Drummond C, de Felice FG, Mattos P. Metabolic syndrome and cognitive decline in the elderly: a systematic review. PLoS One. 2018;13(3):e0194990.
   PubMed Web of Science ®Google Scholar
• Rouch I, Trombert B, Kossowsky MP, Laurent B, Celle S, Ntougou Assoumou G, et al. Metabolic syndrome is associated with poor memory and executive performance in elderly community residents: the PROOF study. Am J Geriatr Psychiatry. 2014;22(11):1096–104.
   PubMed Web of Science ®Google Scholar
• Giugliano D, Ceriello A, Esposito K. Are there specific treatments for the metabolic syndrome? Am J Clin Nutr. 2008;87:8–11.
   PubMed Web of Science ®Google Scholar
• Al-Qawasmeh RH, Tayyem RF. Dietary and lifestyle risk factors and metabolic syndrome: literature review. Curr Res Nutr Food Sci J. 2018;6(3):594–608.
   Web of Science ®Google Scholar
• Plat J, Severins N, Morrison S, Mensink RP. Effects of NWT-03, an egg-protein hydrolysate, on blood pressure in normotensive, high-normotensive and mild-hypertensive men and women: a dose-finding study. Br J Nutr. 2017;117(7):942–50.
   PubMed Web of Science ®Google Scholar
• Wang Y, Landheer S, van Gilst WH, van Amerongen A, Hammes HP, Henning RH, et al. Attenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE- and DPP4-inhibitory activity. PLoS One. 2012;7(10):e46781.
   PubMed Web of Science ®Google Scholar
• Gerstein HC. Cardiovascular and metabolic benefits of ACE inhibition. Moving beyond blood pressure reduction. Diabetes Care. 2000;23(7):882–3.
   PubMed Web of Science ®Google Scholar
• Gilbert MP, Pratley RE. GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials. Front Endocrinol. 2020;11:178.
   PubMed Web of Science ®Google Scholar
• Plat J, Severins N, Mensink RP. Improvement of pulse wave velocity and metabolic cardiovascular risk parameters through egg protein hydrolysate intake: a randomized trial in overweight or obese subjects with IGT or T2DM. J Funct Foods. 2019;52:418–23.
   Web of Science ®Google Scholar
• Barnes JN, Corkery AT. Exercise improves vascular function, but does this translate to the brain? Brain Plast. 2018;4(1):65–79.
   PubMedGoogle Scholar
• Banks WA, Kastin AJ. Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci. 1996;59(23):1923–43.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. IDF consensus worldwide definition of the metabolic syndrome. July 2020 [cited 2021 Dec 8]. Available from: https://idf.org/our-activities/advocacy-awareness/resources-and-tools/60:idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html.
   Google Scholar
• Adam JJ, Jennings S, Bovend'Eerdt TJ, Hurks PP, Van Gerven PW. Switch hands! Mapping temporal dynamics of proactive manual control with anticues. Acta Psychol. 2015;161:137–44.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):449–502.
   PubMed Web of Science ®Google Scholar
• Bartels C, Wegrzyn M, Wiedl A, Ackermann V, Ehrenreich H. Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci. 2010;11:118.
   PubMed Web of Science ®Google Scholar
• Emmerling F, Duecker F, de Graaf TA, Schuhmann T, Adam JJ, Sack AT. Foresight beats hindsight: the neural correlates underlying motor preparation in the pro- anti-cue paradigm. Brain Behav. 2017;7(5):e00663.
   PubMed Web of Science ®Google Scholar
• Van Gerven PW, Hurks PP, Bovend'Eerdt TJ, Adam JJ. Switch hands! Mapping proactive and reactive cognitive control across the life span. Dev Psychol. 2016;52(6):960–71.
   PubMed Web of Science ®Google Scholar
• Aron AR. From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol Psychiatry. 2011;69(12):e55–68.
   PubMed Web of Science ®Google Scholar
• Adam JJ, van Houdt H, Scholtissen B, Visser-Vandewalle V, Winogrodzka A, Duits A. Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance. Neurosci Lett. 2011;500(2):113–7.
   PubMed Web of Science ®Google Scholar
• Boes AD, Bechara A, Tranel D, Anderson SW, Richman L, Nopoulos P. Right ventromedial prefrontal cortex: a neuroanatomical correlate of impulse control in boys. Soc Cogn Affect Neurosci. 2009;4(1):1–9.
   PubMed Web of Science ®Google Scholar
• Nestler EJ, Hyman SE, Holtzman DM, Malenka RC. Higher cognitive function and behavioral control. molecular neuropharmacology: a foundation for clinical neuroscience, 3e. New York (NY): McGraw-Hill Education; 2015.
   Google Scholar
• Sarter M, Givens B, Bruno JP. The cognitive neuroscience of sustained attention: where top-down meets bottom-up. Brain Res. 2001;35:146–60.
   Web of Science ®Google Scholar
• Colcombe S, Kramer AF. Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci. 2003;14(2):125–30.
   PubMed Web of Science ®Google Scholar
• Rameshrad M, Razavi BM, Ferns GAA, Hosseinzadeh H. Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning. Daru. 2019;27(1):341–60.
   PubMed Web of Science ®Google Scholar
• Liu Z, Xu L, Xing M, Xu X, Wei J, Wang J, et al. Trelagliptin succinate: DPP-4 inhibitor to improve insulin resistance in adipocytes. Biomed Pharmacother. 2020;125:109952.
   PubMed Web of Science ®Google Scholar
• Gabbouj S, Ryhanen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S, et al. Altered insulin signaling in Alzheimer's disease brain – special emphasis on PI3K-Akt pathway. Front Neurosci. 2019;13:629.
   PubMed Web of Science ®Google Scholar
• Zaulkffali AS, Md Razip NN, Syed Alwi SS, Abd Jalil A, Abd Mutalib MS, Gopalsamy B, et al. Vitamins D and E stimulate the PI3K-AKT signalling pathway in insulin-resistant SK-N-SH neuronal cells. Nutrients. 2019;11(10):2525.
   PubMed Web of Science ®Google Scholar
• Darsalia V, Johansen OE, Lietzau G, Nystrom T, Klein T, Patrone C. Dipeptidyl peptidase-4 inhibitors for the potential treatment of brain disorders; a mini-review with special focus on linagliptin and stroke. Front Neurol. 2019;10:493.
   PubMed Web of Science ®Google Scholar
• Dumbrill JL, Moulton CD. Effects of incretin-based therapies on neurocognitive function in humans: a systematic review of the literature. Prim Care Diabetes. 2018;12(1):51–8.
   PubMed Web of Science ®Google Scholar
• Milstein JL, Ferris HA. The brain as an insulin-sensitive metabolic organ. Mol Metab. 2021;52:101234.
   PubMed Web of Science ®Google Scholar
• Strachan MW. Insulin and cognitive function in humans: experimental data and therapeutic considerations. Biochem Soc Trans. 2005;33(5):1037–40.
   PubMedGoogle Scholar
• Cetinkalp S, Simsir IY, Ertek S. Insulin resistance in brain and possible therapeutic approaches. Curr Vasc Pharmacol. 2014;12(4):553–64.
   PubMed Web of Science ®Google Scholar
• Gravesteijn E, Mensink RP, Plat J. Effects of nutritional interventions on BDNF concentrations in humans: a systematic review. Nutr Neurosci. 2021;25(7):1425–36.
   PubMed Web of Science ®Google Scholar
• Kowianski P, Lietzau G, Czuba E, Waskow M, Steliga A, Morys J. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol. 2018;38(3):579–93.
   PubMed Web of Science ®Google Scholar
• Yang D, Nakajo Y, Iihara K, Kataoka H, Yanamoto H. Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice. Brain Res. 2013;1517:104–13.
   PubMed Web of Science ®Google Scholar
• Markus CR, Verschoor E, Firk C, Kloek J, Gerhardt CC. Effect of tryptophan-rich egg protein hydrolysate on brain tryptophan availability, stress and performance. Clin Nutr. 2010;29(5):610–6.
   PubMed Web of Science ®Google Scholar
• Mohajeri MH, Wittwer J, Vargas K, Hogan E, Holmes A, Rogers PJ, et al. Chronic treatment with a tryptophan-rich protein hydrolysate improves emotional processing, mental energy levels and reaction time in middle-aged women. Br J Nutr. 2015;113(2):350–65.
   PubMed Web of Science ®Google Scholar
• Gibson EL, Vargas K, Hogan E, Holmes A, Rogers PJ, Wittwer J, et al. Effects of acute treatment with a tryptophan-rich protein hydrolysate on plasma amino acids, mood and emotional functioning in older women. Psychopharmacology. 2014;231(24):4595–610.
   PubMed Web of Science ®Google Scholar
• Riedel WJ, Sobczak S, Schmitt AJ. Tryptophan modulation and cognition. Adv Exp Med Biol. 2003;527:207–13.
   PubMed Web of Science ®Google Scholar
• Kang YK, Lee BY, Bucci LR, Stohs SJ. Effect of a fibroin enzymatic hydrolysate on memory improvement: a placebo-controlled, double-blind study. Nutrients. 2018;10(2):233.
   PubMed Web of Science ®Google Scholar
• Xu T, Yu X, Perlik AJ, Tobin WF, Zweig JA, Tennant K, et al. Rapid formation and selective stabilization of synapses for enduring motor memories. Nature. 2009;462(7275):915–9.
   PubMed Web of Science ®Google Scholar
• Lumsden J, Skinner A, Coyle D, Lawrence N, Munafo M. Attrition from web-based cognitive testing: a repeated measures comparison of gamification techniques. J Med Internet Res. 2017;19(11):e395.
   PubMed Web of Science ®Google Scholar
• Matthews G, Warm JS, Smith AP. Task engagement and attentional resources. Hum Factors. 2017;59(1):44–61.
   PubMed Web of Science ®Google Scholar